Treatment of a Complex Personality Disorder Using Repeated Doses of LSD-A Case Report on Significant Improvements in the Absence of Acute Drug Effects
This case study of a patient with mental health problems, found no acute effects of LSD (50 to 200 µg) and persistent (7 days) positive effects (dose-dependent) on depression (TRD) and suicidal ideation scores.
Authors
- Stefan Borgwardt
- Matthias Liechti
- Friederike Holze
Published
Abstract
A 39-year-old female patient suffering from severe, treatment-resistant depression and other symptoms associated with a complex personality disorder was admitted to our open psychiatric ward for an experimental treatment with lysergic acid diethylamide (LSD). The substance was administered in repeated weekly and ascending doses. Curiously, there were no substantial acute subjective effects of the drug despite adequate dosing, which was also confirmed by plasma drug concentration monitoring. However, the patient showed rapid and significant improvement with most notable changes in depressed mood, emotional instability, loss of energy, and suicidal ideations. Additionally, the SCL-90 questionnaire indicated significant decreases in global severity and in various psychopathological subscales. Improvements persisted for ~7 days after each administration. Due to the severe course of the illness and the resistance to previous treatment it was decided to continue this experimental approach with weekly repeated doses of LSD. The patient will be observed closely with regard to somatic and mental side effects. Two features of this case are remarkable: Firstly, administration of LSD was associated with significant improvements in various symptoms of a condition usually difficult to treat. Secondly, symptom reductions occurred in the absence of acute drug effects. Therefore, the mechanism of action seemed to deviate from the concept that improvements after administration of drugs like LSD are due to experiences during the acute drug effects. This case might indicate that LSD can induce rapid but transient beneficial effects on several psychopathological symptoms. The time course of these improvements resembled antidepressant effects seen after administration of ketamine.
Research Summary of 'Treatment of a Complex Personality Disorder Using Repeated Doses of LSD-A Case Report on Significant Improvements in the Absence of Acute Drug Effects'
Introduction
Earlier research has reported that limited administrations of serotonergic hallucinogens and MDMA can produce sustained improvements in anxiety and depressive symptoms, an effect commonly attributed to subjective experiences during the acute drug state. Despite such findings, uncertainty remains about whether the acute phenomenology is necessary for therapeutic benefit and how these compounds behave in patients with complex, treatment-resistant psychopathology. Müller and colleagues report a single-case experimental treatment in a 39-year-old woman with severe, treatment-resistant depression and a mixed personality disorder. The report documents the clinical course following initial MDMA exposures and then repeated, ascending weekly doses of LSD, with attention to both symptomatic change and the unexpected absence of typical acute psychedelic effects despite pharmacokinetic confirmation of drug exposure. The case is presented to explore clinical response patterns and possible mechanisms when symptomatic improvements occur without pronounced acute subjective effects.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typeindividual
- Journal
- Compound
- Topics
- Authors
- APA Citation
Müller, F., Mühlhauser, M., Holze, F., Lang, U. E., Walter, M., Liechti, M. E., & Borgwardt, S. (2020). Treatment of a Complex Personality Disorder Using Repeated Doses of LSD-A Case Report on Significant Improvements in the Absence of Acute Drug Effects. Frontiers in Psychiatry, 11. https://doi.org/10.3389/fpsyt.2020.573953
References (7)
Papers cited by this study that are also in Blossom
Kirchner, K. · Journal of Psychopharmacology (2014)
Grob, C. S., Mithoefer, M. C., Brewerton, T. D. · Lancet Psychiatry (2016)
Nichols, D. E. · Pharmacological Reviews (2016)
Holze, F., Vizeli, P., Müller, F. et al. · Neuropsychopharmacology (2019)
Mithoefer, A. T., Mithoefer, M. C., Feduccia, A. A. et al. · Lancet Psychiatry (2018)
Liechti, M. E., Dolder, P. C., Schmid, Y. · Psychopharmacology (2016)
Kuypers, K. P. C., Erritzoe, D., Knudsen, G. M. et al. · Journal of Psychopharmacology (2019)
Cited By (4)
Papers in Blossom that reference this study
Seybert, C., Schimmers, N., Silva, L. et al. · Lancet (2024)
Marrocu, A., Kettner, H., Weiss, B. et al. · Journal of Psychopharmacology (2024)
Madsen, M. K., Petersen, A. S., Stenbæk, D. S. et al. · Headache (2024)
Breeksema, J. J., Kuin, B. W., Kamphuis, J. et al. · Journal of Psychopharmacology (2022)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.